)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals (EYPT) investor relations material
EyePoint Pharmaceuticals Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary4 Mar, 2026
Executive summary
Advanced pivotal Phase III trials for DURAVYU in wet AMD and DME, with first patients dosed in both DME studies and topline data for wet AMD expected in mid-2026 and DME in the second half of 2027.
Maintained a strong cash position of $306 million at year-end 2025, supporting operations into Q4 2027 and positioning for transformative growth with multiple near-term inflection points.
Appointed a new Chief Commercial Officer to lead DURAVYU launch strategy and readiness.
Expanded commercial leadership and manufacturing capabilities, including operational Massachusetts facility, to support future product launch and regulatory submissions.
Financial highlights
Ended 2025 with $306 million in cash and investments, bolstered by a $173 million follow-on financing in October.
Q4 2025 net revenue was $0.6 million, down from $11.6 million in Q4 2024, mainly due to lower license and royalty revenue and prior deferred revenue recognition.
Q4 2025 operating expenses rose to $71 million from $57 million year-over-year, driven by Phase III trial costs.
Q4 2025 net loss was $68 million ($0.81/share), compared to $41 million ($0.64/share) in Q4 2024.
Full-year 2025 net revenue was $31.4 million, down from $43.3 million in 2024; net loss was $232 million ($3.17/share) versus $131 million ($2.32/share) in 2024.
Outlook and guidance
Cash and investments expected to fund operations into Q4 2027, covering key milestones and NDA preparation for wet AMD and DME programs.
Top-line data for Phase III wet AMD program expected in mid-2026, with DME data anticipated in the second half of 2027.
Focused on completing DME Phase III enrollment in H2 2026 and preparing for regulatory filings, assuming positive data.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next EyePoint Pharmaceuticals earnings date
RBC Capital Markets Virtual Ophthalmology Conference25 Mar, 2026
EyePoint Pharmaceuticals
Next EyePoint Pharmaceuticals earnings date
RBC Capital Markets Virtual Ophthalmology Conference25 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
EyePoint Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing ophthalmic therapies. The company specializes in sustained-release drug delivery technologies to address serious eye diseases, including conditions affecting the retina and anterior segment of the eye. EyePoint’s product portfolio includes treatments for inflammation and other ocular disorders, and it supports both commercialized products and clinical development programs. The company is headquartered in Watertown, Massachusetts, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage